Arphra/Issuer/WAT

WAT

Waters Corporation

HealthcareMedical - Diagnostics & ResearchUSUSD

$371.93

-1.06%LiveJun 02, 2026

AI Brief

Market cap

$24.24B

52w range

275.05 – 414.15

P / E

—

EPS

—

Volume

523.01K

Revenue · FY

$3.17B

+6.99% YoY

Explain this page

Arphra AIPlain-English read on Waters Corporation’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

$1.78M

4 txns

Sold

$4.88M

6 txns

Net flow

−$3.09M

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$301.38

Change

-13.74%

Period high

$412.54

Period low

$277.72

Period start

$349.392025-06-03

Through 2026-05-04

Peers

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
-1.65%	+1.28%	+21.10%	+19.15%	-6.46%	-2.08%	+6.45%	+43.30%	+17.60%	+168.77%	+9736.17%

Aftermarket

Live

Jun 02, 10:55 PM

Last trade

$371.93

1 sh

Bid

$365.00

1 sh

Ask

$375.00

12 sh

Spread

$10.000

Sector & industry today

Live

Sectors

Technology
+1.59%
Industrials
+1.50%
Energy
+1.40%
Basic Materials
+1.36%
Utilities
+0.94%
Consumer Cyclical
+0.45%
Real Estate
+0.37%
Consumer Defensive
+0.28%
Financial Services
+0.05%
Healthcare
-0.26%
Communication Services
-0.39%

Top industries (issuer's industry highlighted)

Medical - Diagnostics & Research
-0.90%
Hardware, Equipment & Parts
+5.17%
Computer Hardware
-4.64%
REIT - Office
+4.28%
Communication Equipment
+4.02%
Electronic Gaming & Multimedia
-3.94%
Real Estate - Services
+3.82%
Agricultural - Machinery
+3.64%
Auto - Parts
+3.58%
Oil & Gas Energy
+3.45%
Information Technology Services
+3.19%
Copper
+3.00%

Fair value

Football field →

Weighted blend

$347.97

-6.44% vs spot

Recommendation

Underweight

15 of 16 methods

Method spread

3bull11bear

±5% threshold

Analyst PT consensus: $402.57 (+8.24%)

Total assets

$5.08B

Total debt

$1.41B

Cash & equiv

$587.83M

Operating CF

$652.56M

Free cash flow

$539.81M

Buybacks

-$14.67M

Analyst view

DB · price_targets + analyst_grades

Consensus target

$402.57

+8.24% upside

Low

$350.00

Median

$400.00

High

$480.00

Recent actions

0 ↑0 ↓8 hold

Apr 01, 2026
Mar 01, 2026
Feb 01, 2026
Jan 01, 2026
Dec 01, 2025

News

DB · news_items

No recent news for WAT.

Recent quarters

All financials →

Period	Revenue	Net income	EPS
Q4 Dec 2025	$932.36M	$225.21M	$3.77
Q3 Sep 2025	$799.89M	$148.92M	$2.50
Q2 Jun 2025	$771.33M	$147.11M	$2.47
Q1 Mar 2025	$661.71M	$121.38M	$2.03
Q4 Dec 2024	$872.71M	$231.4M	$3.88
Q3 Sep 2024	$740.31M	$161.5M	$2.71

Recent insiders

All →

Insider	Action	Shares	Value	Date
Jiang Wei director	Buy	500	$144.73K	Mar 16, 2026
FEARON RICHARD H director	Buy	1,000	$306.34K	Mar 06, 2026
FEARON RICHARD H director	Buy	1,000	$332.9K	May 28, 2024
KUEBLER CHRISTOPHER A director	Sell	4,000	$1.45M	May 15, 2024
BADDOUR LINDA director	Sell	500	$177.77K	Mar 13, 2024
KUEBLER CHRISTOPHER A director	Sell	4,000	$1.17M	Aug 04, 2023

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2025	$3.17B	$893.22M	$642.63M	$10.76	+20.30%
FY 2024	$2.96B	$826.35M	$637.83M	$10.71	+21.56%
FY 2023	$2.96B	$817.68M	$642.23M	$10.84	+21.72%
FY 2022	$2.97B	$873.4M	$707.76M	$11.73	+23.81%
FY 2021	$2.79B	$821.71M	$692.84M	$11.17	+24.87%